Article Details
Retrieved on: 2024-07-15 21:31:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On July 15, 2024, Benitec Biopharma Inc. (the “Company”) issued a press release announcing interim clinical trial data from its BB-301 Phase 1b/2a ...
Article found on: quantisnow.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here